Skip to Main Content

INFORMATION FOR

    Promoting HIV risk reduction among people who inject drugs: A stepped care approach using contingency management with PrEP navigation

    Organizations

    Description

    Introduction

    This project will test a stepped care intervention called CM2PN, combining contingency management with pre-exposure prophylaxis (PrEP) navigation, to promote sustained PrEP adherence and reduce HIV risk among people who inject drugs in Connecticut and Massachusetts. By adapting support to individual needs, the study aims to improve engagement in HIV prevention, opioid use disorder care, and harm reduction, potentially informing new strategies for high-risk populations.

    Overview

    People who inject drugs (PWID) face significant barriers to accessing proven HIV prevention tools such as syringe service programs, medications for opioid use disorder, and pre-exposure prophylaxis (PrEP). In regions like Connecticut and Massachusetts, many PWID remain underserved, in part due to limited engagement with routine medical care and persistent structural challenges. Existing interventions often fail to address these layered obstacles, and there is limited evidence on strategies that effectively promote sustained PrEP adherence within this population. This research responds to the urgent need for adaptive, community-based approaches that can overcome both individual and systemic barriers to HIV prevention. The project will evaluate a stepped care intervention, CM2PN, which combines contingency management with PrEP navigation to support ongoing PrEP use and reduce HIV risk among PWID. By tailoring support based on participants’ progress, the study seeks to improve engagement in prevention, substance use treatment, and harm reduction activities. Findings could inform best practices for reaching high-risk groups and help guide implementation of flexible, resource-efficient HIV prevention strategies. Ultimately, this work aims to advance public health efforts to reduce new HIV infections in vulnerable communities.

    Themes

    Collaborators

    Leadership

    • E. Jennifer Edelman, MD, MHS, AAHIVS

      Principal Investigator
      Yale School of Medicine

      Professor of Medicine (General Medicine)

    Research Team

    Name
    Title
    Institution
    Dini Harsono, MSc
    Program Director, Health Services and Global ResearchYale School of Medicine

    Outcomes

    Publications

    Funding

    Grants

    Promoting HIV risk reduction among people who inject drugs: A stepped care approach using contingency management with PrEP navigation

    IRB/ID
    R01DA051871
    07/01/2020 - 05/31/2026
    Funding Source
    National Institute on Drug Abuse